Thermo Fisher Scientific Inc. (US) and GenScript (US) are Leading Players in the Custom Antibody Market
The custom antibody market is expected to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The major factors driving the growth of this market include the rising demand for personalized medicines, the increase in the global prevalence of chronic diseases, and the advancements in genetic engineering.
The global custom antibody market is consolidated with top players such as Thermo Fisher Scientific Inc. (US), GenScript (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), and Agilent Technologies, Inc. (US). The market players have adopted various strategies such as new product launches, acquisitions, agreements, partnerships, and geographical expansions to strengthen their position in the global custom antibody market.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific Inc. (US)
Thermo Fisher Scientific is one of the leading players in the life science industry. The company develops, manufactures, sells, and distributes reagents & consumables, software, and services. The company is known for its premier brands, such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. With a global presence and a reputation for high-quality products and innovative technologies, Thermo Fisher Scientific is a trusted partner for laboratories, research institutions, and pharmaceutical companies involved in custom antibody development and production. Their commitment to advancing scientific research and improving patient outcomes makes them a key player in the custom antibody market. The company operates in over 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. Further, the company continues to invest in research and development to offer innovative and a broad range of products. For instance, in 2023, the company invested USD 1.34 billion in research and development.
GenScript (US)
GenScript is a leading biotech company providing life sciences services and products. The company offers services and products for gene synthesis, oligonucleotide synthesis, peptide synthesis, protein production, antibody development, and various other applications. These services and products are used in various life science research & application areas, including basic biology studies, pharmaceuticals & drug discovery, diseases & vaccines, and diagnostics. The company caters to pharmaceutical and biotech companies, research institutes, and government bodies (including government testing & diagnostic centers) through its sales and distribution offices network. To sustain itself in this competitive market, the company focuses on strategic agreements and collaborations with various pharmaceutical companies and research institutions. For instance, in September 2022, GenScript and the Institute of Genomic Immunology collaborated with researchers to develop new non-viral cell therapies that modify genomic sequences for advanced, effective cell therapy products.
Merck KGaA (Germany)
Merck KGaA is a healthcare & life sciences company that develops, manufactures, and markets pharmaceutical and biopharmaceutical products, specialty chemicals, high-tech materials, and life science research and diagnostic tools. The company offers custom antibody development and production for research and IVD development applications. The company has a strong international presence, with a wide distribution network and established relationships with research institutions, biotech, and pharmaceutical companies worldwide. Additionally, the company has strategically expanded its global footprint by developing collaborations and partnerships. For instance, in December 2022, Merck KGaA collaborated with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates (ADC) for cancer treatment.
Related Reports:
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
